A Woman With Treatment-Resistant Hypertension.
暂无分享,去创建一个
[1] S. Laurent,et al. Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors. , 2014, European heart journal.
[2] Michael Böhm,et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.
[3] N. Chapman,et al. Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension , 2007, Hypertension.
[4] G. Mitchell,et al. Central pressure should not be used in clinical practice. , 2014, Artery research.
[5] M. Caulfield,et al. Joint UK societies’ 2014 consensus statement on renal denervation for resistant hypertension , 2014, Heart.
[6] Krzysztof Bartus,et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study , 2009, The Lancet.
[7] M. Schlaich. Biomarkers for the prediction of blood pressure response to renal denervation: a long way to go. , 2014, Hypertension.
[8] J. Staessen,et al. Blood pressure changes after renal denervation at 10 European expert centers , 2013, Journal of Human Hypertension.
[9] T. Unger,et al. Key advances in antihypertensive treatment , 2012, Nature Reviews Cardiology.
[10] H. Krum,et al. Novel procedure- and device-based strategies in the management of systemic hypertension. , 2011, European heart journal.
[11] A. Dominiczak,et al. Eligibility for Renal Denervation: Experience at 11 European Expert Centers , 2014, Hypertension.
[12] C. Hamm,et al. Soluble fms-Like Tyrosine Kinase-1 and Endothelial Adhesion Molecules (Intercellular Cell Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1) as Predictive Markers for Blood Pressure Reduction After Renal Sympathetic Denervation , 2014, Hypertension.
[13] J. Sharman. Central pressure should be used in clinical practice , 2014 .
[14] Alice Stanton,et al. Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study , 2006, Circulation.
[15] Stephen D. Persell. Prevalence of Resistant Hypertension in the United States, 2003–2008 , 2011, Hypertension.
[16] Deepak L. Bhatt,et al. Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety , 2014, The New England journal of medicine.
[17] Nilesh J Samani,et al. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis , 2014, Heart.